IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 143 filers reported holding IMMUNOGEN INC in Q2 2015. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $242,000 | -13.3% | 90,600 | 0.0% | 0.01% | -14.3% |
| Q2 2016 | $279,000 | -63.8% | 90,600 | 0.0% | 0.01% | -58.8% |
| Q1 2016 | $771,000 | -37.3% | 90,600 | 0.0% | 0.02% | -37.0% |
| Q4 2015 | $1,229,000 | +41.4% | 90,600 | 0.0% | 0.03% | +12.5% |
| Q3 2015 | $869,000 | -33.3% | 90,600 | 0.0% | 0.02% | -7.7% |
| Q2 2015 | $1,302,000 | +60.7% | 90,600 | 0.0% | 0.03% | +62.5% |
| Q1 2015 | $810,000 | +46.7% | 90,600 | 0.0% | 0.02% | +45.5% |
| Q4 2014 | $552,000 | -42.4% | 90,600 | 0.0% | 0.01% | -45.0% |
| Q3 2014 | $959,000 | -10.6% | 90,600 | 0.0% | 0.02% | +5.3% |
| Q2 2014 | $1,073,000 | -2.3% | 90,600 | +23.1% | 0.02% | -5.0% |
| Q1 2014 | $1,098,000 | +1.8% | 73,600 | 0.0% | 0.02% | +5.3% |
| Q4 2013 | $1,079,000 | -13.8% | 73,600 | 0.0% | 0.02% | -17.4% |
| Q3 2013 | $1,252,000 | +2.5% | 73,600 | 0.0% | 0.02% | 0.0% |
| Q2 2013 | $1,221,000 | – | 73,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
| Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
| Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
| Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
| Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
| Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
| Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
| PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |